Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg
Description
In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention (7 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
Prof Carol Wham
Malnutrition and frailty in older adults - The importance of screening and early intervention
Prof Andrew Sindone
Heart failure and obesity - Which do we manage first?
A/Prof Ron Dick
Why is LDL control important?
Dr Danielle Einstein & Brett Lee
The social media ban - Practical preparation for children and families
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
